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Supplemental Data
Supplementary Figure S1 . Electrophoretic mobility of antithrombin London. A) SDS under reducing conditions and silver staining of purified α-antithrombin and antithrombin London (Δ393). B) Nondenaturing electrophoresis and identification by western blot of purified α-antithrombin and antithrombin London (Δ393). Lanes were loaded with 150 ng protein. Figure S2 . Loss of inhibitory function and prothrombotic gain of function associated with antithrombin Δ393. A) Time course inhibition of thrombin by antithrombin evaluated by a chromogenic method in a continuous method in the presence of two different amounts of unfractionated heparin. Antithrombin concentration was 10-fold higher than thrombin to asses pseudo-first order conditions. B) Thrombin-antithrombin complexes detected by SDS-PAGE and western blot. The formation of thrombin-antithrombin complex was evaluated by incubation of 150 ng α-antithrombin with 0.25 U thrombin and incubated at 37 ºC. Figure S3 . Conformational instability of ΔR393 antithrombin (Antithrombin London). A) Plot obtained by differential scanning calorimetry (DSC) of wild type antithrombin (left) and melting temperature calculated after data fitting (right). B) Plot obtained by DSC of antithrombin London where no thermal transition was detected. C) Gel filtration chromatography of London (black) and wild type (grey) antithrombins previous to DSC measurements. D) Thermal stability of antithrombin London (dashed line) and wild type (continuous line) measured by changes in circular dichroism at 222 nm. Figure S4 . Immunostaining of the same membrane shown in figure  2C : 2.5 µM 125 I-radiolabeled wild type antithrombin added to 1µL control plasma and 1µL plasma of carriers of P1 mutants heated at 42ºC up to 3 d. Samples were run in native gels.
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